September 30, 2024

Roflumilast Cream Effective for Atopic Dermatitis in Phase III Trials

Two phase III clinical trials reveal promising results of once-daily roflumilast cream, 0.15%, in improving symptoms of atopic dermatitis within 4 weeks.

Conexiant

September 25, 2024

Home vs. Office: Psoriasis Treatment Showdown

Home-based narrowband UV-B phototherapy for psoriasis achieved superior treatment adherence, with 51.4% of patients receiving at least 24 treatments compared to only 15.9% in the office-based group.

Conexiant

September 23, 2024

New Biomarkers Reveal Topical Treatment Effects

Optical coherence tomography reveals betamethasone induces 2.3 times more epidermal thinning than crisaborole in atopic dermatitis patients after 4 weeks of treatment.

Conexiant

September 17, 2024

Epidermal Thinning from Atopy Treatments Compared

Study reveals betamethasone induces 2.3 times more epidermal thinning than crisaborole in atopic dermatitis patients, identified through novel non-invasive biomarkers.

Conexiant

September 16, 2024

FDA Approves New Eczema Drug

Approval is based on 3 studies involving over 1,000 patients with moderate-to-severe eczema who had inadequate responses to topical or systemic treatments.

Reuters

September 09, 2024

Vitamin E May Help Reduce Atopic Dermatitis Risk

Other antioxidant vitamins such as vitamin C, carotene, and retinol may have no significant effect.

Conexiant

April 26, 2024

Wildfires May Have Triggered Skin Disease Flare-ups in Northeastern United States

The number of visits to dermatologists for atopic dermatitis and eczema may have increased during the summer months of 2023 following the Canadian wildfires.

Conexiant

May 28, 2024

Study Links Blood Pressure Meds to Eczema Risk in Seniors

Antihypertensive drugs linked to small increased risk of eczema in older adults, with diuretics and calcium channel blockers showing the highest risk, study finds.

Conexiant

June 03, 2024

New Topical Antipruritic Spray Shows Promise in Treating EGFR-Related Dermatitis

A new study reveals the efficacy of a topical antipruritic spray containing traditional Chinese medicine ingredients in treating EGFR-related dermatitis in cancer patients.

Conexiant